Merck & Co., Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, Merck & Co., Inc. reported net income of $18.25B on revenue of $65.01B. Operating cash flow was $16.47B and capital expenditures were $4.11B, leaving $12.36B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.81B | $40.12B | $42.29B | $39.12B | $41.52B | $48.70B | $59.28B | $60.12B | $64.17B | $65.01B |
| Net income | $3.92B | $2.39B | $6.22B | $9.84B | $7.07B | $13.05B | $14.52B | $365.00M | $17.12B | $18.25B |
| Diluted EPS | $1.41 | $0.87 | $2.32 | $3.81 | $2.78 | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 |
| Operating cash flow | $10.38B | $6.45B | $10.92B | $13.44B | $10.25B | $13.12B | $19.09B | $13.01B | $21.47B | $16.47B |
| Capital expenditures | — | — | — | — | — | $4.45B | $4.39B | $3.86B | $3.37B | $4.11B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | — | — | 28.1% |
| Dec 2024 | — | — | 26.7% |
| Dec 2023 | — | — | 0.6% |
| Dec 2022 | — | — | 24.5% |
| Dec 2021 | — | — | 26.8% |
Source: SEC EDGAR XBRL company facts for CIK 310158 (raw data). Most recent filing in this dataset: 10-Q filed Aug 7, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.